Form D · Pharmaceuticals
Reven Pharmaceuticals, Inc.
Sarasota, FL · CIK 0001556231
Offering snapshot reported Feb 18, 2015 · SEC filing
- Reported sold
- $4.44M Offering amount: $7M
- Investors reported
- 48 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jan 8, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 48
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 18, 2015 | Amendment | $4,440,594 | No comparison | 48 | SEC filing |
| Feb 19, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 29, 2014 | Amendment | $1,833,055 | $1,307,030vs Jun 5, 2013 | 36 | SEC filing |
| Jun 5, 2013 | Amendment | $526,025 | $503,525vs Mar 8, 2013 | 16 | SEC filing |
| Mar 8, 2013 | Initial | $22,500 | No comparison | 2 | SEC filing |
| Jan 28, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-212162
Source: Form D, filed Feb 18, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Denomme | Director, Executive |
| Michael Handley | Executive |
| Peter B. Lange | Director, Executive |
| Michael A. Volk | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4411 Bee Ridge Road Suite 285
Sarasota, FL, 34233
Sarasota, FL, 34233